Last updated: 2026-09-07 21:59:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
DarioHealth Corp. (DRIO) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $7,22, with a market capitalization of $70,95M and a P/E ratio of 0,01. Over the past 52 weeks, its price has ranged from $5,84 to $17,74. This page covers its latest market performance, valuation, price trends and company information.
$70,95M | |
$6,94 | |
$2.360,00 | |
$5,84 | |
$6,98 | |
20,23K | |
22,32K | |
0,01 | |
$17,74 | |
$5,84 | |
-- | |
-- |
DarioHealth Corp. (DRIO) last closed at $6,98 as of 2026-09-05 00:00:00, unchanged from the previous close of $6,98.
During the latest regular trading session, DRIO traded between $5,84 and $2.360,00, with a volume of 20,23K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, DarioHealth Corp. (DRIO) moved from $6,77 to $7,22, representing a gain of 6,57% ($0,45).
The stock traded between $6,45 and $7,62 during the period. The latest price is near the middle of the 7-day range, indicating strong upward.
The average daily volume was 31,01 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 11,5%
DRIO is currently trading at $7,22, placing it 11,5% of the way from its 52-week low of $5,84 to its 52-week high of $17,74. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 165 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of DarioHealth Corp. (DRIO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.